SCHEMBL10546416

SCHEMBL10546416

O=C(O)c1cnc(S)n1Cc1cccc(CO)c1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 7/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ F10 P00742 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ GPR35 Q9HC97 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ ACMSD Q8TDX5 1/20 0.36
▸ CD74 P04233 1/20 0.36
▸ MIF P14174 1/20 0.36
▸ PLA2G10 O15496 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10548634 0.82 CCR2 (0.56) CCR2TSHRMAPK1
SCHEMBL10543693 0.82 CCR2 (0.56) CCR2CYP11B1CYP11B2POLB
SCHEMBL10543086 0.80 CNR2 (0.46) CCR2TSHRSMN1; SMN2MAPK1
SCHEMBL10546918 0.76 CCR2 (0.37) CCR2MAPK1
SCHEMBL15654050 0.76 PKM (0.49) CCR2CYP11B1CYP11B2POLBSMN1; SMN2
SCHEMBL7165398 0.70 POLB (0.63) POLBHTTMAPK1
SCHEMBL11340082 0.70 PTGDR2 (0.41) —
SCHEMBL1752323 0.70 GPR35 (0.40) POLBTSHRGPR35MAPK1
SCHEMBL7247406 0.69 XDH (0.46) CYP11B1CYP11B2POLBHTTSMN1; SMN2
SCHEMBL4418297 0.67 HPGDS (0.51) CCR2POLBTSHRSMN1; SMN2GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4859779-A ENZYME INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1989-08-22 — — US disclosed
US-4837353-A 2-/N-PHENYLALKYL-N-FORMYL/AMINO-3-HYDROXY-2-PROPENOIC ACID DERIVATIVES SMITHKLINE BECKMAN CORPORATION (US) 1989-06-06 — — US disclosed
EP-0284375-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1988-09-28 — — EP disclosed
US-4762850-A Dopamine-beta-hydroxylase inhibitors SMITHKLINE BECKMAN CORPORATION (US) 1988-08-09 — — US disclosed
Send feedback